Patrick C. Ma

7.1k citations
33 papers · 5.0k · 4 hit papers · h-index 16

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • HER2/EGFR in Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Immunotherapy and Biomarkers 7
    • Lung Cancer Research Studies 3
    • HER2/EGFR in Cancer Research 2
    • Lung Cancer Treatments and Mutations 11
    • Sarcoma Diagnosis and Treatment 2

Patrick C. Ma

31 papers receiving 5.0k citations

Patrick C. Ma's Hit Papers

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial 2020 · 1.4k citations
1.4k0+3+6Years since publication50010001.5k2.0k

Peers

Patrick C. Ma
Comparison fields: 5 of 110
  • Oncology 2.5k
  • Cancer Research 1.0k
  • Pulmonary and Respiratory Medicine 1.4k
  • Neurology 381
  • Pathology and Forensic Medicine 399
Replace Wolfgang Michael Korn with:
Wolfgang Michael Korn United States
Valentina Boni Spain
Emiliano Cocco United States
Collin Michael Blakely United States
Zachary Rockow Chalmers United States
Roland Penzel Germany
Lavinia Anne Spain United Kingdom
Jan Willem B. de Groot Netherlands
Anas Gazzah France
Alexander Quaas Germany
Patrick C. Ma relative to Wolfgang Michael Korn United States Wolfgang Michael Korn's profile →
Citations per field
00.5×1.6×
Wolfgang Michael Korn · 1×
Citations per year

Countries citing papers authored by Patrick C. Ma

Since Specialization
Citations

This map shows the geographic impact of Patrick C. Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Ma more than expected).

Fields of papers citing papers by Patrick C. Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Ma. The network helps show where Patrick C. Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick C. Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick C. Ma Line = papers co-authored together Patrick C. Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Hit paper breakdown →
20182120
2
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Hit paper breakdown →
20201374
3
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Hit paper breakdown →
2017491
4
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Hit paper breakdown →
2019457
5 2019184
6 202152
7 201938
8 202035
9 201734
10 202129
11 202128
12 201023
13 202220
14 202419
15 202219
16 202518
17 202415
18 202114
19 201714
20 202413

About Patrick C. Ma

Patrick C. Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Molecular Biology, having authored 33 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Research Studies (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer-related molecular mechanisms research (2 papers), Genetic factors in colorectal cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.0k citations), Pulmonary and Respiratory Medicine (1.4k citations), Neurology (381 citations) and Pathology and Forensic Medicine (399 citations). Patrick C. Ma has collaborated with scholars based in United States, Austria and Australia. Frequent co-authors include Zuan-Fu Lim, Daniel Morgensztern, Bryan T. Oronsky, Corey A. Carter, Alexander Spira, Stephen V. Liu, Ari VanderWalde, Hossein Borghaei, Edward S. Kim and Wolfgang Michael Korn. Their work appears in journals such as JCO Precision Oncology, Cancer Research, Lung Cancer, The Oncologist and Translational Lung Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact